Home › Oncothyreon makes breast cancer drug deal with Array, stock surges Friday
 

Keywords :   


Oncothyreon makes breast cancer drug deal with Array, stock surges Friday

2014-12-15 16:30:40| Biotech - Topix.net

Oncothyreon Inc. on Friday said it made a licensing deal with Array BioPharma Inc. regarding a breast cancer drug that received "positive preliminary data" in two recent trials, and its shares rose sharply on the news. In the licensing deal for ONT-380, Oncothyreon will pay Array $20 million upfront and up to $280 million in possible milestone payments.

Tags: makes stock friday deal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.06May placements exceed expectations in June cattle on feed report
27.06Modern and precise: Using gene editing to change the blueprint of an organism
27.06Atlantic Tropical Weather Outlook
27.06Eastern North Pacific Tropical Weather Outlook
27.06What is 'AI washing' and why is it a problem?
27.06Higher U.S. prices push beef exports to shrink; domestic demand holding steady
27.06Cost of summer cookout reaches record high
26.06Denmark to tax emissions from farmers in pioneering move
More »